According to a new report from Intel Market Research, the global Degarelix market was valued at USD 320 million in 2024 and is projected to reach USD 520 million by 2034, growing at a steady CAGR of 5.8% during the forecast period (2025-2034). This growth is driven by rising prostate cancer incidence globally, increased adoption of advanced hormonal therapies, and expanding treatment...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek